Niacin and Enbrel drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Niacin (niacin) and Enbrel (etanercept). Common drug interactions include erythema among females and anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Niacin and Enbrel. It is created by eHealthMe based on reports of 120 people who take the same drugs from the FDA, and is updated regularly.
What is Niacin?
Niacin has active ingredients of niacin. It is often used in high blood cholesterol. eHealthMe is studying from 9,009 Niacin users. Check the latest studies of Niacin.
What is Enbrel?
Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
120 people who take Niacin and Enbrel together, and have interactions are studied.

What are the common drug interactions of Niacin and Enbrel, by gender? *
What are the common drug interactions of Niacin and Enbrel, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Niacin and Enbrel?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Niacin and Enbrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Niacin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Enbrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Niacin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Enbrel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Loebl T, Raskin S, "A novel case report: acute manic psychotic episode after treatment with niacin", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
- Loebl T, Raskin S, "A novel case report: acute manic psychotic episode after treatment with niacin", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on niacin and etanercept (the active ingredients of Niacin and Enbrel, respectively), and Niacin and Enbrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cisplatin and Gemcitabine Hydrochloride drug interactions for boys aged 10-19 - 13 seconds ago
- Could Clozapine cause Torsade De Pointes? - 20 seconds ago
- Could Magnesium cause Interstitial Lung Disease? - 26 seconds ago
- Drug interactions of Mycophenolate Mofetil and Marijuana - 28 seconds ago
- Adcirca and Sucralfate drug interactions for women aged 60+ - 39 seconds ago
- Vitamin D3 and Gastroesophageal Reflux Disease for Women aged 60+ - 50 seconds ago
- Vitamin D3 and Gastrooesophageal Reflux Disease for Women aged 60+ - 50 seconds ago
- Vitamin D3 and Reflux for Women aged 60+ - 50 seconds ago
- Vitamin D3 and Heartburn for Women aged 60+ - 51 seconds ago
- Vitamin D3 and Non-Cardiac Chest Pain for Women aged 60+ - 51 seconds ago